SB
IVA

Samsara BioCapital’s Inventiva IVA Stock Holding History

Samsara BioCapital’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8M Hold
5,194,805
– – 2.8% 8
2025
Q4 		$24.2M Buy
+5,194,805
New +$24.1M 2.49% 7

Other funds holding IVA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM

Samsara BioCapital's IVA Position: Q1 2026 in Review

Samsara BioCapital held its Inventiva (IVA) position steady in Q1 2026 at 5,194,805 shares worth $28.8M. The position accounts for 2.8% of the portfolio, ranked #8.

Samsara BioCapital first reported a position in IVA in Q4 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

  • Samsara BioCapital held 5,194,805 shares of Inventiva worth $28.8M as of Q1 2026.
  • Samsara BioCapital left its Inventiva share count unchanged in Q1 2026.
  • Inventiva made up 2.8% of Samsara BioCapital's portfolio in Q1 2026, its #8 holding.
  • Samsara BioCapital first reported a position in Inventiva in Q4 2025 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on Samsara BioCapital's 13F filing for Q1 2026, filed 15 May 2026.